Colistimethate Injection, Powder, For Solution
Product Images NDC 0143-9443

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Colistimethate (NDC 0143-9443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Colistimethate For Injection Usp 1)

Chemical structure of Colistimethate Sodium shown as a molecular diagram with repeating units of amino acids and sulfonated groups labeled with sodium ions.*

FDA Label Image

Figure 1 (Colistimethate For Injection Usp 2)

A line graph illustrating urine and serum colistimethate base activity levels (mcg/mL) over time (hours) in adults following parenteral administration (intramuscular or intravenous) of Colistimethate for Injection. Separate lines represent intravenous and intramuscular routes for both urine and serum measurements, showing changes in concentration up to 12 hours post-administration.*

FDA Label Image

Vial Label (Colistimethate For Injection Usp 3)

Label for Colistimethate for Injection USP, 150 mg/vial (colistin base activity) powder for solution by Hikma Pharmaceuticals USA Inc. Intended for intramuscular and intravenous use. Contains storage instructions, manufacturer address, barcode, and placeholder areas for lot and expiration dates.*

FDA Label Image

Carton (Colistimethate For Injection Usp 4)

Packaging label for Colistimethate for Injection, USP, 150 mg vial with colistin base activity. The label indicates the product is for intramuscular and intravenous use, prescription only, and manufactured for Hikma Pharmaceuticals USA Inc. The label includes storage instructions, dosing information, and a barcode, and it specifies one 150 mg vial per package.*

FDA Label Image

Carton 12 (Colistimethate For Injection Usp 5)

Packaging label for Colistimethate for Injection, USP 150 mg per vial, powder for solution. Label indicates colistin base activity with 12 x 150 mg vials per package. Manufactured by Hikma Pharmaceuticals USA Inc. for intramuscular and intravenous use. Storage instructions and dosing information included on label. NDC 0143-9443-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.